European Journal of Internal Medicine, ISSN 0953-6205, 02/2019, Volume 60, pp. 54 - 70
Who should be tested for viruses in patients with community acquired pneumonia (CAP), prevalence and risk factors for viral CAP are still debated. We evaluated...
Oseltamivir | Viral pneumonia | Community acquired pneumonia | Influenza | Viral swab | Testing | PNEUMONIA | UNITED-STATES | ETIOLOGY | ADULTS | COINFECTION | MEDICINE, GENERAL & INTERNAL | STAPHYLOCOCCUS-AUREUS | INFECTION | CRITICALLY-ILL PATIENTS | VIRUSES | Prospective Studies | Community-Acquired Infections - epidemiology | Cross-Sectional Studies | Antiviral Agents - therapeutic use | Oseltamivir - therapeutic use | Humans | Middle Aged | Pneumonia, Viral - drug therapy | Influenza, Human - epidemiology | Logistic Models | Male | Hospitalization | Medication Adherence | Pneumonia, Viral - epidemiology | Community-Acquired Infections - drug therapy | Internationality | Aged, 80 and over | Female | Aged | Influenza, Human - drug therapy | Databases, Factual
Oseltamivir | Viral pneumonia | Community acquired pneumonia | Influenza | Viral swab | Testing | PNEUMONIA | UNITED-STATES | ETIOLOGY | ADULTS | COINFECTION | MEDICINE, GENERAL & INTERNAL | STAPHYLOCOCCUS-AUREUS | INFECTION | CRITICALLY-ILL PATIENTS | VIRUSES | Prospective Studies | Community-Acquired Infections - epidemiology | Cross-Sectional Studies | Antiviral Agents - therapeutic use | Oseltamivir - therapeutic use | Humans | Middle Aged | Pneumonia, Viral - drug therapy | Influenza, Human - epidemiology | Logistic Models | Male | Hospitalization | Medication Adherence | Pneumonia, Viral - epidemiology | Community-Acquired Infections - drug therapy | Internationality | Aged, 80 and over | Female | Aged | Influenza, Human - drug therapy | Databases, Factual
Journal Article
Brain, ISSN 0006-8950, 10/2015, Volume 138, Issue 10, pp. 2847 - 2858
Haematopoietic stem cell transplantation has been proposed as treatment for mitochondrial neurogastrointestinal encephalomyopathy, a rare fatal autosomal...
risk factors | mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) | MNGIE | thymidine phosphorylase | THYMIDINE PHOSPHORYLASE-DEFICIENCY | FANCONI-ANEMIA | allogeneic haematopoietic stem cell transplantation | Journal Article | Research Support, N.I.H., Extramural | Research Support, Non-U.S. Gov't | DISORDER | Multicenter Study | PATIENT | MUTATIONS | OUTCOMES | DELETIONS | outcome | NEUROSCIENCES | CLINICAL NEUROLOGY | Mitochondrial Encephalomyopathies - surgery | Body Weight | Follow-Up Studies | Humans | Neutrophils | Male | Neural Conduction - physiology | Treatment Outcome | Young Adult | Magnetic Resonance Imaging | Neurologic Examination | Adolescent | Survival Analysis | Brain - pathology | Adult | Female | Intestinal Pseudo-Obstruction - surgery | Retrospective Studies | Hematopoietic Stem Cell Transplantation - methods | Child | Thymidine Phosphorylase - metabolism | Transplantation, Homologous - methods | Original | 1070
risk factors | mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) | MNGIE | thymidine phosphorylase | THYMIDINE PHOSPHORYLASE-DEFICIENCY | FANCONI-ANEMIA | allogeneic haematopoietic stem cell transplantation | Journal Article | Research Support, N.I.H., Extramural | Research Support, Non-U.S. Gov't | DISORDER | Multicenter Study | PATIENT | MUTATIONS | OUTCOMES | DELETIONS | outcome | NEUROSCIENCES | CLINICAL NEUROLOGY | Mitochondrial Encephalomyopathies - surgery | Body Weight | Follow-Up Studies | Humans | Neutrophils | Male | Neural Conduction - physiology | Treatment Outcome | Young Adult | Magnetic Resonance Imaging | Neurologic Examination | Adolescent | Survival Analysis | Brain - pathology | Adult | Female | Intestinal Pseudo-Obstruction - surgery | Retrospective Studies | Hematopoietic Stem Cell Transplantation - methods | Child | Thymidine Phosphorylase - metabolism | Transplantation, Homologous - methods | Original | 1070
Journal Article
Clinical Genetics, ISSN 0009-9163, 09/2014, Volume 86, Issue 3, pp. 258 - 263
We analysed the clinical history of 16 hemizygous males affected by Anderson‐Fabry Disease, from four families, to verify their intrafamilial phenotypic...
genetic counselling | GLA gene | agalsidase alpha | Anderson‐Fabry disease | Fabry | phenotypic heterogeneity | alpha‐galactosidase deficiency | intrafamilial variability | agalsidase beta | Anderson-Fabry disease | Agalsidase beta | Alpha-galactosidase deficiency | Intrafamilial variability | Genetic counselling | Phenotypic heterogeneity | Agalsidase alpha | X-INACTIVATION | OUTCOME SURVEY | alpha-galactosidase deficiency | GENE | GENETICS & HEREDITY | MUTATIONS | ENZYME REPLACEMENT THERAPY | ALPHA-GALACTOSIDASE | Fabry Disease - genetics | Humans | Middle Aged | Male | Fabry Disease - pathology | Mutation, Missense - genetics | Hemizygote | Fabry Disease - mortality | Phenotype | Pedigree | Adult | Fabry Disease - drug therapy | Enzyme Replacement Therapy - statistics & numerical data | Development and progression | Fabry's disease | Medical research | Genotype & phenotype | Genetic disorders | Risk factors
genetic counselling | GLA gene | agalsidase alpha | Anderson‐Fabry disease | Fabry | phenotypic heterogeneity | alpha‐galactosidase deficiency | intrafamilial variability | agalsidase beta | Anderson-Fabry disease | Agalsidase beta | Alpha-galactosidase deficiency | Intrafamilial variability | Genetic counselling | Phenotypic heterogeneity | Agalsidase alpha | X-INACTIVATION | OUTCOME SURVEY | alpha-galactosidase deficiency | GENE | GENETICS & HEREDITY | MUTATIONS | ENZYME REPLACEMENT THERAPY | ALPHA-GALACTOSIDASE | Fabry Disease - genetics | Humans | Middle Aged | Male | Fabry Disease - pathology | Mutation, Missense - genetics | Hemizygote | Fabry Disease - mortality | Phenotype | Pedigree | Adult | Fabry Disease - drug therapy | Enzyme Replacement Therapy - statistics & numerical data | Development and progression | Fabry's disease | Medical research | Genotype & phenotype | Genetic disorders | Risk factors
Journal Article
Pulmonary Pharmacology & Therapeutics, ISSN 1094-5539, 2014, Volume 27, Issue 2, pp. 129 - 138
Abstract Randomized Controlled Trials (RCTs) are the “gold standard” for evaluating treatment outcomes providing information on treatments “efficacy”. They are...
Medical Education | Pulmonary/Respiratory | Real life studies | Randomized controlled trials | Asthma | COPD | COST-EFFECTIVENESS | PROPENSITY SCORE | INHALED CORTICOSTEROIDS | ASTHMA CONTROL | OBSTRUCTIVE PULMONARY-DISEASE | CIGARETTE-SMOKING | PRIMARY-CARE | SURVEILLANCE BIAS | RESPIRATORY SYSTEM | CONSORT STATEMENT | PHARMACOLOGY & PHARMACY | PRAGMATIC TRIALS | Asthma - therapy | Pulmonary Disease, Chronic Obstructive - therapy | Confounding Factors (Epidemiology) | Randomized Controlled Trials as Topic - methods | Research Design | Humans | Health aspects | Lung diseases, Obstructive | Methods
Medical Education | Pulmonary/Respiratory | Real life studies | Randomized controlled trials | Asthma | COPD | COST-EFFECTIVENESS | PROPENSITY SCORE | INHALED CORTICOSTEROIDS | ASTHMA CONTROL | OBSTRUCTIVE PULMONARY-DISEASE | CIGARETTE-SMOKING | PRIMARY-CARE | SURVEILLANCE BIAS | RESPIRATORY SYSTEM | CONSORT STATEMENT | PHARMACOLOGY & PHARMACY | PRAGMATIC TRIALS | Asthma - therapy | Pulmonary Disease, Chronic Obstructive - therapy | Confounding Factors (Epidemiology) | Randomized Controlled Trials as Topic - methods | Research Design | Humans | Health aspects | Lung diseases, Obstructive | Methods
Journal Article
Clinical Microbiology and Infection, ISSN 1198-743X, 10/2012, Volume 18, Issue 5, pp. 7 - 14
causes different types of acute, invasive and non-invasive clinical infections, being the most frequently detected pathogen responsible for community-acquired...
cost of disease | vaccine | Antibiotic resistance | infection prevention | Streptococcus pneumoniae | Infection prevention | Vaccine | Cost of disease | UNITED-STATES | INFECTIOUS DISEASES | COMMUNITY-ACQUIRED PNEUMONIA | MICROBIOLOGY | ANTIMICROBIAL RESISTANCE | PREVENTING PNEUMONIA | BACTERIAL PNEUMONIA | STREPTOCOCCUS-PNEUMONIAE | DOUBLE-BLIND TRIAL | CONJUGATE-VACCINE | MACROLIDE RESISTANCE | POLYSACCHARIDE VACCINE | Pneumococcal Infections - drug therapy | Streptococcus pneumoniae - drug effects | Community-Acquired Infections - epidemiology | Humans | Bacteremia - drug therapy | Drug Resistance, Bacterial | Pneumococcal Vaccines - administration & dosage | Anti-Bacterial Agents - therapeutic use | Pneumococcal Infections - epidemiology | Bacteremia - prevention & control | Community-Acquired Infections - drug therapy | Treatment Failure | Pneumococcal Infections - prevention & control | Pneumococcal Vaccines - immunology | Bacteremia - epidemiology | Anti-Bacterial Agents - pharmacology | Community-Acquired Infections - prevention & control | Drug resistance in microorganisms | Anti-infective agents | Respiratory agents | Pneumonia | Adults | Bacterial pneumonia
cost of disease | vaccine | Antibiotic resistance | infection prevention | Streptococcus pneumoniae | Infection prevention | Vaccine | Cost of disease | UNITED-STATES | INFECTIOUS DISEASES | COMMUNITY-ACQUIRED PNEUMONIA | MICROBIOLOGY | ANTIMICROBIAL RESISTANCE | PREVENTING PNEUMONIA | BACTERIAL PNEUMONIA | STREPTOCOCCUS-PNEUMONIAE | DOUBLE-BLIND TRIAL | CONJUGATE-VACCINE | MACROLIDE RESISTANCE | POLYSACCHARIDE VACCINE | Pneumococcal Infections - drug therapy | Streptococcus pneumoniae - drug effects | Community-Acquired Infections - epidemiology | Humans | Bacteremia - drug therapy | Drug Resistance, Bacterial | Pneumococcal Vaccines - administration & dosage | Anti-Bacterial Agents - therapeutic use | Pneumococcal Infections - epidemiology | Bacteremia - prevention & control | Community-Acquired Infections - drug therapy | Treatment Failure | Pneumococcal Infections - prevention & control | Pneumococcal Vaccines - immunology | Bacteremia - epidemiology | Anti-Bacterial Agents - pharmacology | Community-Acquired Infections - prevention & control | Drug resistance in microorganisms | Anti-infective agents | Respiratory agents | Pneumonia | Adults | Bacterial pneumonia
Journal Article
International journal of chronic obstructive pulmonary disease, ISSN 1176-9106, 2019, Volume 14, pp. 1 - 11
Background: Patient awareness of COPD refers to knowledge and acceptance of the disease and its treatment. Although it is relevant to management and outcomes,...
Questionnaire | Patient satisfaction | Awareness | COPD | questionnaire | PERSPECTIVE | KNOWLEDGE | VALIDATION | CLASSIFICATION | ILLNESS | RELIABILITY | ADHERENCE | patient satisfaction | OBSTRUCTIVE PULMONARY-DISEASE | awareness | RESPIRATORY SYSTEM | VALIDITY
Questionnaire | Patient satisfaction | Awareness | COPD | questionnaire | PERSPECTIVE | KNOWLEDGE | VALIDATION | CLASSIFICATION | ILLNESS | RELIABILITY | ADHERENCE | patient satisfaction | OBSTRUCTIVE PULMONARY-DISEASE | awareness | RESPIRATORY SYSTEM | VALIDITY
Journal Article
The Journal of Allergy and Clinical Immunology: In Practice, ISSN 2213-2198, 05/2019, Volume 7, Issue 5, pp. 1643 - 1646
Elevated airway eosinophil counts can be detected in more than 50% of asthmatics and associated with more symptoms, frequent exacerbations, and greater airflow...
BIOMARKERS | ALLERGY | IMMUNOLOGY | Respiratory tract | Leukocytes (eosinophilic) | Nitric oxide | Immunoglobulin E | Monoclonal antibodies | Blood | Asthma
BIOMARKERS | ALLERGY | IMMUNOLOGY | Respiratory tract | Leukocytes (eosinophilic) | Nitric oxide | Immunoglobulin E | Monoclonal antibodies | Blood | Asthma
Journal Article
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ISSN 1178-2005, 2019, Volume 14, pp. 2185 - 2193
While chronic obstructive pulmonary disease (COPD) continues to be a major cause of morbidity and mortality, pharmacological therapy has a definite benefit on...
CHRONIC-BRONCHITIS | BLOOD EOSINOPHILS | COMBINATION THERAPY | LAMA | FLUTICASONE FUROATE | exacerbation | OBSTRUCTIVE PULMONARY-DISEASE | SPUTUM EOSINOPHILIA | RESPIRATORY SYSTEM | LABA | PARALLEL-GROUP | DOUBLE-BLIND | EXACERBATIONS | AIRWAY EOSINOPHILIA | deprescribing | COPD | inhaled corticosteroids | Tiotropium | Lung diseases, Obstructive | Care and treatment | Corticosteroids | Mortality | Pharmaceutical industry | Health aspects | Switzerland
CHRONIC-BRONCHITIS | BLOOD EOSINOPHILS | COMBINATION THERAPY | LAMA | FLUTICASONE FUROATE | exacerbation | OBSTRUCTIVE PULMONARY-DISEASE | SPUTUM EOSINOPHILIA | RESPIRATORY SYSTEM | LABA | PARALLEL-GROUP | DOUBLE-BLIND | EXACERBATIONS | AIRWAY EOSINOPHILIA | deprescribing | COPD | inhaled corticosteroids | Tiotropium | Lung diseases, Obstructive | Care and treatment | Corticosteroids | Mortality | Pharmaceutical industry | Health aspects | Switzerland
Journal Article
Respiratory Medicine, ISSN 0954-6111, 2006, Volume 100, Issue 10, pp. 1767 - 1774
The aim of our study was to assess the prevalence of anxiety and depression in the whole chronic obstructive pulmonary disease (COPD) population and in...
Depression | Anxiety | Dyspnea | COPD | Quality of life | CARDIAC & CARDIOVASCULAR SYSTEMS | dyspnea | PREVALENCE | CANCER | anxiety | OBSTRUCTIVE PULMONARY-DISEASE | IMPACT | THERAPY | INVENTORY | RESPIRATORY SYSTEM | ELDERLY PATIENTS | depression | QUALITY-OF-LIFE | SCALE | quality of life | Forced Expiratory Volume - physiology | Humans | Male | Dyspnea - etiology | Pulmonary Disease, Chronic Obstructive - physiopathology | Case-Control Studies | Depression - etiology | Pulmonary Disease, Chronic Obstructive - psychology | Sex Factors | Quality of Life | Female | Surveys and Questionnaires | Aged | Anxiety - etiology | Respiratory agents | Lung diseases, Obstructive | Depression, Mental | Prevalence studies (Epidemiology) | Studies | Psychological aspects | Hospitals | Disease | Oxygen therapy | Anxieties | Classification | Questionnaires | Males | Females | Chronic illnesses
Depression | Anxiety | Dyspnea | COPD | Quality of life | CARDIAC & CARDIOVASCULAR SYSTEMS | dyspnea | PREVALENCE | CANCER | anxiety | OBSTRUCTIVE PULMONARY-DISEASE | IMPACT | THERAPY | INVENTORY | RESPIRATORY SYSTEM | ELDERLY PATIENTS | depression | QUALITY-OF-LIFE | SCALE | quality of life | Forced Expiratory Volume - physiology | Humans | Male | Dyspnea - etiology | Pulmonary Disease, Chronic Obstructive - physiopathology | Case-Control Studies | Depression - etiology | Pulmonary Disease, Chronic Obstructive - psychology | Sex Factors | Quality of Life | Female | Surveys and Questionnaires | Aged | Anxiety - etiology | Respiratory agents | Lung diseases, Obstructive | Depression, Mental | Prevalence studies (Epidemiology) | Studies | Psychological aspects | Hospitals | Disease | Oxygen therapy | Anxieties | Classification | Questionnaires | Males | Females | Chronic illnesses
Journal Article
International Journal of Fatigue, ISSN 0142-1123, 09/2019, Volume 126, pp. 306 - 318
The Strain Energy Density (SED) fatigue criterion is based on a material control radius. The value of this length is therefore required for an accurate...
Inverse search | SED | Control radius | V-notched specimen | Conventionally and additively manufactured alloys | CRITICAL DISTANCES | MATERIALS SCIENCE, MULTIDISCIPLINARY | CRACK INITIATION | STRENGTH | BRITTLE-FRACTURE | ENGINEERING, MECHANICAL | FRACTURE ASSESSMENT | MEAN STRESS | STEEL | MULTIAXIAL FATIGUE | STRUCTURAL COMPONENTS | CRITERION | Numerical analysis | Alloys | Notched components | Flux density | Computer simulation | Fatigue strength | Notches
Inverse search | SED | Control radius | V-notched specimen | Conventionally and additively manufactured alloys | CRITICAL DISTANCES | MATERIALS SCIENCE, MULTIDISCIPLINARY | CRACK INITIATION | STRENGTH | BRITTLE-FRACTURE | ENGINEERING, MECHANICAL | FRACTURE ASSESSMENT | MEAN STRESS | STEEL | MULTIAXIAL FATIGUE | STRUCTURAL COMPONENTS | CRITERION | Numerical analysis | Alloys | Notched components | Flux density | Computer simulation | Fatigue strength | Notches
Journal Article
Clinical Microbiology and Infection, ISSN 1198-743X, 01/2019, Volume 25, Issue 1, pp. 111.e1 - 111.e4
Objectives: The aim was to investigate an outbreak of invasive meningococcal disease (IMD) in Southern Sardinia. Methods: Epidemiological and microbiological...
Invasive meningococcal disease | Capsular switching | Outbreak | Whole-genome sequencing | Hypervirulent | Neisseria meningitides | Italy | INFECTIOUS DISEASES | MICROBIOLOGY | Neisseria meningitidis - pathogenicity | Meningococcal Infections - epidemiology | Meningococcal Infections - transmission | Humans | Middle Aged | Virulence | Antigens, Bacterial - immunology | Serogroup | Male | Meningococcal Infections - microbiology | Whole Genome Sequencing | Young Adult | Anti-Bacterial Agents - therapeutic use | Disease Outbreaks | Adolescent | Bacterial Capsules - genetics | Female | Italy - epidemiology | Neisseria meningitidis - genetics | Bacterial Capsules - immunology
Invasive meningococcal disease | Capsular switching | Outbreak | Whole-genome sequencing | Hypervirulent | Neisseria meningitides | Italy | INFECTIOUS DISEASES | MICROBIOLOGY | Neisseria meningitidis - pathogenicity | Meningococcal Infections - epidemiology | Meningococcal Infections - transmission | Humans | Middle Aged | Virulence | Antigens, Bacterial - immunology | Serogroup | Male | Meningococcal Infections - microbiology | Whole Genome Sequencing | Young Adult | Anti-Bacterial Agents - therapeutic use | Disease Outbreaks | Adolescent | Bacterial Capsules - genetics | Female | Italy - epidemiology | Neisseria meningitidis - genetics | Bacterial Capsules - immunology
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 06/2017, Volume 76, Issue Suppl 2, p. 52
BackgroundFibromyalgia (FM) is characterised by chronic musculoskeletal pain, autonomic nervous system (ANS) dysfunction, and disturbed sleep.ObjectivesThe aim...
Fibromyalgia | Sleep (REM) | Nervous system | Heart rate | Sleep disorders | Intolerance | Body mass index | Pain | Autonomic nervous system | Syncope | Vagus nerve | Heart diseases | Sleep and wakefulness
Fibromyalgia | Sleep (REM) | Nervous system | Heart rate | Sleep disorders | Intolerance | Body mass index | Pain | Autonomic nervous system | Syncope | Vagus nerve | Heart diseases | Sleep and wakefulness
Journal Article